In non-small cell lung cancer, miR-342-3p has been suggested to play a tumor-suppressive role by negatively regulating RAP2B (a member of the RAS oncogene family) [68] and MYC transcriptional activity by targeting E2F1 (a MYC-cooperating molecule) [69]. Here, E2F1 is linked to neoplasm.